ציין מניה או מטבע קריפטוגרפי בשורת החיפוש כדי לקבל סיכום
ADDvise Group B
ADDV-BADDvise Group AB (publ) supplies equipment to healthcare and research facilities in private and public sectors in Sweden, rest of Europe, North America, South America, Asia, and internationally. The Lab business unit provides laboratory furnishings, ventilation, climate/clean rooms, and laboratory equipment to pharmaceutical and life science industries. The Healthcare business unit develops and supplies medical equipment, pharmaceuticals, and consumables in areas, such as urology, gynecology, emergency care, and surgery. In addition, it manufactures and sells surgical tables, as well as offers cables, connectors, and wires. Further, the company offers customized solutions for the rental and sale of laboratory and medical equipment for clinical studies; designs and delivers customized cleanrooms, climate rooms, laboratory furniture, air conditioning systems, ventilated protective products, and equipment; distributes medical devices, including continuous glucose monitors and insulin pumps; orthopaedic solutions, including implants, instruments, and technologies; and develops software and instruments to quantify patient mobility, pain, and muscle strength. Additionally, it distributes healthcare and industrial ultrasound devices for healthcare and industrial applications, such as NDT inspections; operates a mail-order pharmacy; develops, manufactures, and markets over-the-counter generic drugs for pain management, coughs, colds, allergies, sinus infections, and urological conditions; products and software to streamline the monitoring of vital signs in patients in long-term care and nursing homes; and develops, manufactures, and markets colorimetric CO2 indicators used in healthcare to monitor breathing in respiratory and emergency care. The company was formerly known as ADDvise Lab Solutions AB (publ). ADDvise Group AB (publ) was incorporated in 1989 and is headquartered in Stockholm, Sweden. Address: Grev Turegatan 30, Stockholm, Sweden, 114 38
Analytics
מחיר יעד של וול סטריט
96.48 SEKיחס רווח למחיר
5.99תשואת דיבידנד
–השנה הנוכחית
שנה שעברה
רבעון נוכחי
רבע אחרון
השנה הנוכחית
שנה שעברה
רבעון נוכחי
רבע אחרון
דמויות מפתח ADDV-B
ניתוח דיבידנדים ADDV-B
Max Ratio
>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - ожидаемая <5 дивидендная доходность по себестоимости за 10 лет MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.
–גידול דיבידנד במשך 5 שנים
–צמיחה מתמשכת
–יחס תשלום ממוצע של 5 שנים
106.00 %היסטוריית דיבידנדים ADDV-B
שווי מניות ADDV-B
פיננסיים ADDV-B
תוצאות | 2019 | דינמיקה |